AGER and breast carcinoma: Evaluating the METABRIC Breast Cancer cohort (https://www.cbioportal.org/), we found that the OS in BC patients exhibiting high expression levels of RAGE was poorer respect to patients harboring low expression levels of RAGE (Fig. 2A).